Terveystalo
9.61
EUR
+1.48 %
TTALO
NASDAQ Helsinki
Medical Equipment & Services
Health Care
11,089 following
www.terveystalo.com/en/company/investors/investor-relations
Terveystalo operates in the healthcare sector. The company offers services and solutions that, for example, concern surveys and examinations, education and coaching, rehabilitation, and health and fitness mapping. The customers are found among small and medium-sized corporate customers, as well as among actors in the public sector. The head office is located in Helsinki.
P/E (adj.) (24e)
12.81
EV/EBIT (adj.) (24e)
12.02
P/B (24e)
2.11
Dividend yield-% (24e)
3.75 %
Target price
10.80 EUR
Recommendation
Accumulate
Updated
11.11.2024
NASDAQ Helsinki
TTALO
Daily low / high price
9.4 / 9.61
EUR
Market cap
1.22B EUR
Turnover
221.79K EUR
Volume
23K
Business risk
Valuation risk
Current
Previous
Analyst
Roni Peuranheimo
Analyst
Financial calendar
Annual report
2025-02-14
General meeting
2025-04-08
Interim report
2025-04-25
Interim report
2025-07-17
Interim report
2025-10-23
Income statement
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
Revenue | 986.4 | 1,154.6 | 1,259.1 | 1,286.5 | 1,343.1 | 1,375.5 | 1,408.2 | 1,441.7 |
growth-% | -4.3 % | 17.1 % | 9.0 % | 2.2 % | 4.4 % | 2.4 % | 2.4 % | 2.4 % |
EBITDA | 158.0 | 198.1 | 168.9 | 179.1 | 222.3 | 245.0 | 252.6 | 257.2 |
EBIT (adj.) | 93.0 | 128.9 | 88.4 | 104.7 | 145.5 | 158.7 | 165.4 | 169.1 |
EBIT | 67.2 | 110.1 | 33.9 | -14.7 | 119.8 | 144.2 | 152.9 | 157.5 |
Profit before taxes | 56.7 | 100.4 | 31.0 | -38.9 | 93.4 | 119.9 | 131.8 | 139.5 |
Net income | 45.9 | 80.0 | 24.5 | -42.2 | 74.8 | 94.7 | 104.1 | 110.2 |
EPS (adj.) | 0.52 | 0.74 | 0.54 | 0.54 | 0.75 | 0.84 | 0.90 | 0.94 |
growth-% | -11.5 % | 42.9 % | -27.8 % | -0.1 % | 40.0 % | 11.5 % | 7.3 % | 4.7 % |
Dividend | 0.26 | 0.28 | 0.28 | 0.30 | 0.36 | 0.40 | 0.42 | 0.44 |
Dividend ratio | 72.5 % | 44.8 % | 145.1 % | -90.2 % | 61.2 % | 53.6 % | 51.2 % | 50.7 % |
Profitability and return on capital
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
EBITDA-% | 16.0 % | 17.2 % | 13.4 % | 13.9 % | 16.6 % | 17.8 % | 17.9 % | 17.8 % |
EBIT-% (adj.) | 9.4 % | 11.2 % | 7.0 % | 8.1 % | 10.8 % | 11.5 % | 11.7 % | 11.7 % |
EBIT-% | 6.8 % | 9.5 % | 2.7 % | -1.1 % | 8.9 % | 10.5 % | 10.9 % | 10.9 % |
ROE | 8.2 % | 13.6 % | 4.1 % | -7.6 % | 13.7 % | 15.7 % | 15.9 % | 15.6 % |
ROI | 5.9 % | 9.6 % | 2.9 % | -1.3 % | 10.4 % | 12.5 % | 13.4 % | 13.8 % |
Valuation
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
Share price (EUR) | 10.04 | 11.84 | 6.25 | 7.74 | 9.61 | 9.61 | 9.61 | 9.61 |
Shares | 128.0 | 128.0 | 127.0 | 127.0 | 127.0 | 127.0 | 127.0 | 127.0 |
Market cap | 1,285.5 | 1,516.0 | 793.8 | 983.3 | 1,220.8 | 1,220.8 | 1,220.8 | 1,220.8 |
Enterprise value | 1,777.1 | 2,035.2 | 1,360.6 | 1,581.3 | 1,749.9 | 1,687.0 | 1,623.4 | 1,558.5 |
EV/S | 1.8 | 1.8 | 1.1 | 1.2 | 1.3 | 1.2 | 1.2 | 1.1 |
EV/EBITDA | 11.2 | 10.3 | 8.1 | 8.8 | 7.9 | 6.9 | 6.4 | 6.1 |
EV/EBIT (adj.) | 19.1 | 15.8 | 15.4 | 15.1 | 12.0 | 10.6 | 9.8 | 9.2 |
EV/EBIT | 26.4 | 18.5 | 40.1 | - | 14.6 | 11.7 | 10.6 | 9.9 |
P/E (adj.) | 19.3 | 15.9 | 11.7 | 14.4 | 12.8 | 11.5 | 10.7 | 10.2 |
P/E | 28.0 | 18.9 | 32.4 | - | 16.3 | 12.9 | 11.7 | 11.1 |
P/B | 2.2 | 2.5 | 1.3 | 1.9 | 2.1 | 1.9 | 1.8 | 1.7 |
P/S | 1.3 | 1.3 | 0.6 | 0.8 | 0.9 | 0.9 | 0.9 | 0.8 |
Dividend yield | 2.6 % | 2.4 % | 4.5 % | 3.9 % | 3.8 % | 4.2 % | 4.4 % | 4.6 % |
Equity ratio | 42.0 % | 42.0 % | 40.0 % | 36.3 % | 40.3 % | 43.9 % | 47.7 % | 51.6 % |
Gearing ratio | 85.9 % | 85.3 % | 95.7 % | 116.0 % | 91.6 % | 74.4 % | 59.2 % | 45.8 % |
Quarter data
Q4/23 | 2023 | Q1/24 | Q2/24 | Q3/24 | Q4/24e | 2024e | Q1/25e | Q2/25e | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 342.5 | 1,286.5 | 350.2 | 340.1 | 295.8 | 356.9 | 1,343.1 | 357.4 | 348.7 |
EBITDA | 52.7 | 179.1 | 61.5 | 50.4 | 49.9 | 60.5 | 222.3 | 65.1 | 61.4 |
EBIT | -58.9 | -14.7 | 35.7 | 24.7 | 24.9 | 34.5 | 119.8 | 39.9 | 36.2 |
Profit before taxes | -66.5 | -38.9 | 29.6 | 17.6 | 18.3 | 27.8 | 93.4 | 33.8 | 30.1 |
Net income | -64.1 | -42.2 | 23.6 | 14.5 | 14.7 | 22.0 | 74.8 | 26.7 | 23.8 |
ShowingAll content types
Terveystalo Oyj: Terveystalo Plc: Managers' Transactions (Hasselberg)
Terveystalo Oyj: Terveystalo Plc: Managers' Transactions (Pullola)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools